Compare · SMTI vs ZBH
SMTI vs ZBH
Side-by-side comparison of Sanara MedTech Inc. (SMTI) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SMTI and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $16.88B, about 83.4x SMTI ($202.4M).
- Over the past year, SMTI is down 23.2% and ZBH is down 5.9% - ZBH leads by 17.2 points.
- ZBH has been more active in the news (15 items in the past 4 weeks vs 10 for SMTI).
- ZBH has more recent analyst coverage (25 ratings vs 5 for SMTI).
- Company
- Sanara MedTech Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $22.24+1.46%
- $87.32+0.01%
- Market cap
- $202.4M
- $16.88B
- 1M return
- +16.56%
- +4.71%
- 1Y return
- -23.18%
- -5.94%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 10
- 15
- Recent ratings
- 5
- 25
Sanara MedTech Inc.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. It also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers; and PULSAR II Advanced Wound Irrigation System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest SMTI
- Director Tanzberger Eric D was granted 5,308 shares, increasing direct ownership by 30% to 22,966 units (SEC Form 4)
- Director Major Eric D was granted 4,846 shares, increasing direct ownership by 52% to 14,232 units (SEC Form 4)
- Director Ortwein Sara N was granted 4,616 shares, increasing direct ownership by 22% to 25,415 units (SEC Form 4)
- Director Nixon Ronald T was granted 4,154 shares, increasing direct ownership by 6% to 68,196 units (SEC Form 4)
- Director Desutter Robert Andrew was granted 5,539 shares, increasing direct ownership by 24% to 28,740 units (SEC Form 4)
- Director Salamone Ann Beal was granted 4,154 shares, increasing direct ownership by 18% to 26,858 units (SEC Form 4)
- Director Mack Roszell Iii was granted 5,308 shares, increasing direct ownership by 32% to 21,842 units (SEC Form 4)
- Director Myers Keith G was granted 4,385 shares, increasing direct ownership by 89% to 9,325 units (SEC Form 4)
- Sanara MedTech Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement
- Chief Executive Officer Yon Seth D covered exercise/tax liability with 3,852 shares, decreasing direct ownership by 3% to 109,546 units (SEC Form 4) (for tax liability)
Latest ZBH
- SEC Form 4 filed by Officer Noor Jehanzeb
- Group President, Asia Pacific Yi Sang sold $413,216 worth of shares (5,000 units at $82.64), decreasing direct ownership by 16% to 27,251 units (SEC Form 4)
- Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form SD filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Bernard Betsy J
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Shapiro Louis
- SEC Form 4 filed by Director Kurdikar Devdatt